Literature DB >> 21217108

Longitudinal change detected by spectral domain optical coherence tomography in the optic nerve head and peripapillary retina in experimental glaucoma.

Nicholas G Strouthidis1, Brad Fortune, Hongli Yang, Ian A Sigal, Claude F Burgoyne.   

Abstract

PURPOSE: To investigate whether longitudinal changes deep within the optic nerve head (ONH) are detectable by spectral domain optical coherence tomography (SDOCT) in experimental glaucoma (EG) and whether these changes are detectable at the onset of Heidelberg Retina Tomography (HRT; Heidelberg Engineering, Heidelberg, Germany)-defined surface topography depression.
METHODS: Longitudinal SDOCT imaging (Spectralis; Heidelberg Engineering) was performed in both eyes of nine rhesus macaques every 1 to 3 weeks. One eye of each underwent trabecular laser-induced IOP elevation. Four masked operators delineated internal limiting membrane (ILM), retinal nerve fiber layer (RNFL), Bruch's membrane/retinal pigment epithelium (BM/RPE), neural canal opening (NCO), and anterior lamina cribrosa surface (ALCS) by using custom software. Longitudinal changes were assessed and compared between the EG and control (nonlasered) eyes at the onset of HRT-detected surface depression (follow-up 1; [FU1]) and at the most recent image (follow-up 2; [FU2]).
RESULTS: Mean IOP in EG eyes was 7.1 to 24.6 mm Hg at FU1 and 13.5 to 31.9 mm Hg at FU2. In control eyes, the mean IOP was 7.2 to 12.6 mm Hg (FU1) and 8.9 to 16.0 mm Hg (FU2). At FU1, neuroretinal rim decreased and ALCS depth increased significantly (paired t-test, P < 0.01); no change in RNFL thickness was detected. At FU2, however, significant prelaminar tissue thinning, posterior displacement of NCO, and RNFL thinning were observed.
CONCLUSIONS: Longitudinal SDOCT imaging can detect deep ONH changes in EG eyes, the earliest of which are present at the onset of HRT-detected ONH surface height depression. These parameters represent realistic targets for SDOCT detection of glaucomatous progression in human subjects.

Entities:  

Mesh:

Year:  2011        PMID: 21217108      PMCID: PMC3101662          DOI: 10.1167/iovs.10-5599

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  35 in total

1.  The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography.

Authors:  C Bowd; R N Weinreb; J M Williams; L M Zangwill
Journal:  Arch Ophthalmol       Date:  2000-01

2.  Longitudinal changes in the visual field and optic disc in glaucoma.

Authors:  Paul H Artes; Balwantray C Chauhan
Journal:  Prog Retin Eye Res       Date:  2005-01-24       Impact factor: 21.198

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography.

Authors:  Felipe A Medeiros; Linda M Zangwill; Christopher Bowd; Roberto M Vessani; Remo Susanna; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2005-01       Impact factor: 5.258

5.  Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography.

Authors:  J S Schuman; M R Hee; C A Puliafito; C Wong; T Pedut-Kloizman; C P Lin; E Hertzmark; J A Izatt; E A Swanson; J G Fujimoto
Journal:  Arch Ophthalmol       Date:  1995-05

6.  Global and regional detection of induced optic disc change by digitized image analysis.

Authors:  C F Burgoyne; R Varma; H A Quigley; S Vitale; M E Pease; P L Lenane
Journal:  Arch Ophthalmol       Date:  1994-02

7.  Three-dimensional reconstruction of normal and early glaucoma monkey optic nerve head connective tissues.

Authors:  Claude F Burgoyne; J Crawford Downs; Anthony J Bellezza; Richard T Hart
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-12       Impact factor: 4.799

8.  Identification of early glaucoma cases with the scanning laser ophthalmoscope.

Authors:  G Wollstein; D F Garway-Heath; R A Hitchings
Journal:  Ophthalmology       Date:  1998-08       Impact factor: 12.079

9.  Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma.

Authors:  Anthony J Bellezza; Christopher J Rintalan; Hilary W Thompson; J Crawford Downs; Richard T Hart; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

10.  Ultrahigh-speed optical coherence tomography for three-dimensional and en face imaging of the retina and optic nerve head.

Authors:  Vivek J Srinivasan; Desmond C Adler; Yueli Chen; Iwona Gorczynska; Robert Huber; Jay S Duker; Joel S Schuman; James G Fujimoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-24       Impact factor: 4.799

View more
  88 in total

1.  Effect of acute intraocular pressure elevation on the monkey optic nerve head as detected by spectral domain optical coherence tomography.

Authors:  Nicholas G Strouthidis; Brad Fortune; Hongli Yang; Ian A Sigal; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-09       Impact factor: 4.799

2.  Influence of clinically invisible, but optical coherence tomography detected, optic disc margin anatomy on neuroretinal rim evaluation.

Authors:  Alexandre S C Reis; Neil O'Leary; Hongli Yang; Glen P Sharpe; Marcelo T Nicolela; Claude F Burgoyne; Balwantray C Chauhan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

3.  Expansions of the neurovascular scleral canal and contained optic nerve occur early in the hypertonic saline rat experimental glaucoma model.

Authors:  Marta Pazos; Hongli Yang; Stuart K Gardiner; William O Cepurna; Elaine C Johnson; John C Morrison; Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2015-10-22       Impact factor: 3.467

Review 4.  The morphological difference between glaucoma and other optic neuropathies.

Authors:  Claude Burgoyne
Journal:  J Neuroophthalmol       Date:  2015-09       Impact factor: 3.042

5.  Lamina cribrosa depth according to the level of axial length in normal and glaucomatous eyes.

Authors:  Sung-Cheol Yun; In Kyun Hahn; Kyung Rim Sung; Joo Young Yoon; Daun Jeong; Ho Seok Chung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-13       Impact factor: 3.117

6.  In vivo optic nerve head biomechanics: performance testing of a three-dimensional tracking algorithm.

Authors:  Michaël J A Girard; Nicholas G Strouthidis; Adrien Desjardins; Jean Martial Mari; C Ross Ethier
Journal:  J R Soc Interface       Date:  2013-07-24       Impact factor: 4.118

7.  Longitudinal detection of optic nerve head changes by spectral domain optical coherence tomography in early experimental glaucoma.

Authors:  Lin He; Hongli Yang; Stuart K Gardiner; Galen Williams; Christy Hardin; Nicholas G Strouthidis; Brad Fortune; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

8.  Association of Functional Loss With the Biomechanical Response of the Optic Nerve Head to Acute Transient Intraocular Pressure Elevations.

Authors:  Tin A Tun; Eray Atalay; Mani Baskaran; Monisha E Nongpiur; Hla M Htoon; David Goh; Ching-Yu Cheng; Shamira A Perera; Tin Aung; Nicholas G Strouthidis; Michaël J A Girard
Journal:  JAMA Ophthalmol       Date:  2018-02-01       Impact factor: 7.389

9.  Retinal nerve fiber layer atrophy is associated with visual field loss over time in glaucoma suspect and glaucomatous eyes.

Authors:  Mitra Sehi; Xinbo Zhang; David S Greenfield; Yunsuk Chung; Gadi Wollstein; Brian A Francis; Joel S Schuman; Rohit Varma; David Huang
Journal:  Am J Ophthalmol       Date:  2012-10-01       Impact factor: 5.258

10.  Glaucoma progression detection using nonlocal Markov random field prior.

Authors:  Akram Belghith; Christopher Bowd; Felipe A Medeiros; Madhusudhanan Balasubramanian; Robert N Weinreb; Linda M Zangwill
Journal:  J Med Imaging (Bellingham)       Date:  2014-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.